AI Tool to Reduce Clinician Documentation Burden (NCT07498582) | Clinical Trial Compass
CompletedNot Applicable
AI Tool to Reduce Clinician Documentation Burden
United States128 participantsStarted 2026-03-30
Plain-language summary
This study looks at whether a clinician-facing artificial intelligence (AI) tool can help outpatient doctors spend less time reviewing medical records and documenting care. The tool creates brief summaries of existing medical record information to support routine clinical work. This study examines how use of this tool affects clinicians' workload, time spent in the electronic health record, and overall experience with documentation. The goal is to better understand whether AI documentation support tools can improve efficiency and reduce burden for clinicians in outpatient specialty practice.
Eligible UNC outpatient specialists may be invited to complete surveys and, if they qualify, are randomly assigned either to receive access to the tool (Evidently) at the beginning of the study period or to continue their usual workflow for eight weeks before receiving access. The study does not recruit patients and does not change medical care for patients.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Participants must meet all of the following criteria:
* Attending outpatient specialists affiliated with UNCFP or UNCMG.
* At least two half-days (≥3.5 hours per session) of scheduled outpatient clinic per week.
* Primary specialty in an outpatient, patient-facing specialty practice within UNCFP or UNCMG.
Anesthesiologists will be enrolled under the same protocol but analyzed separately due to distinct workflow characteristics.
Exclusion Criteria:
Clinicians meeting any of the following criteria will be excluded:
* Trainees (e.g., residents or fellows).
* Advanced practice providers (APPs).
* Attendings whose outpatient workflows are predominantly supervisory or shared with trainees or APPs, defined as clinicians who self-report that 25% or more of outpatient clinic sessions are conducted jointly with trainees or APPs.
* Clinicians who participated in a prior Evidently pilot study.
* Clinicians with planned time away exceeding one week during the study period. Exclusion criteria will be assessed using self-report in the baseline survey, supplemented by administrative records where available (e.g., prior pilot participation or clinic volume). Clinicians meeting any exclusion criterion will not be randomized.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.